CSUI
Cannabis Suisse Corp. [CSUI] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CSUI Stock Summary
In the News
CSUI Financial details
Company Rating
Sell
Market Cap
1.02M
Income
-326.85K
Revenue
17.5K
Book val./share
-0.01
Cash/share
0
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
28 Feb 2023
P/E
-2.98
Forward P/E
-
PEG
-1.79
P/S
58.15
P/B
-2.53
P/C
-
P/FCF
-9.31
Quick Ratio
-
Current Ratio
0.01
Debt / Equity
-1.65
LT Debt / Equity
-0.82
-
-
EPS (TTM)
-0.01
EPS next Y
-
EPS next Q
2.09
EPS this Y
19.7%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
81.6%
Revenue last 5Y
5.84%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-33.33%
SMA50
-33.33%
SMA100
-60%
Inst Own
-
Inst Trans
-
ROA
-102%
ROE
108%
ROC
4.37%
Gross Margin
8%
Oper. Margin
-1766%
Profit Margin
-1868%
Payout
-
Shs Outstand
46.25M
Shs Float
33.85M
-
-
-
-
Target Price
-
52W Range
0.015-0.15
52W High
-
52W Low
-
RSI
43.56
Rel Volume
0.4
Avg Volume
24.86K
Volume
10K
Perf Week
-20.86%
Perf Month
-15.38%
Perf Quarter
-72.15%
Perf Half Y
-72.15%
-
-
-
-
Beta
-3.684
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.022
Change
0%
CSUI Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-05-31
| Metric | History | 2019-05-31 | 2020-05-31 | 2021-05-31 | 2022-05-31 | 2023-05-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0.01 | 0 | 0 | 0 | |
| Net income per share | 0 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Operating cash flow per share | 0 | -0.01 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | -0.01 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | 0 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Tangible book value per share | 0 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Share holders equity per share | 0 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Interest debt per share | 0 | 0.01 | 0 | 0.01 | 0.01 | |
| Market cap | 49.38M | 17.84M | 2.52M | 611.78K | 3.5M | |
| Enterprise value | 49.29M | 18.03M | 2.59M | 746.78K | 4.18M | |
| P/E ratio | -2.17K | -45.84 | -5.34 | -2.8 | -9.95 | |
| Price to sales ratio | 6.56K | 73.5 | 49.53 | 78.74 | 349.81 | |
| POCF ratio | -4.16K | -61.77 | -19.28 | -19.07 | -21.33 | |
| PFCF ratio | -4.16K | -61.77 | -19.28 | -19.07 | -21.33 | |
| P/B Ratio | 2.48K | -46.16 | -13.43 | -2.23 | -10.62 | |
| PTB ratio | 2.48K | -46.16 | -13.43 | -2.23 | -10.62 | |
| EV to sales | 6.55K | 74.28 | 50.85 | 96.11 | 418.2 | |
| Enterprise value over EBITDA | -2.86K | -54.43 | -7.69 | -4.81 | -12.36 | |
| EV to operating cash flow | -4.16K | -62.43 | -19.8 | -23.27 | -25.51 | |
| EV to free cash flow | -4.16K | -62.43 | -19.8 | -23.27 | -25.51 | |
| Earnings yield | 0 | -0.02 | -0.19 | -0.36 | -0.1 | |
| Free cash flow yield | 0 | -0.02 | -0.05 | -0.05 | -0.05 | |
| Debt to equity | 0 | -0.49 | -0.36 | -0.49 | -1.45 | |
| Debt to assets | 0 | 0.49 | 10.23 | 0 | 1.38 | |
| Net debt to EBITDA | 4.89 | -0.57 | -0.2 | -0.87 | -2.02 | |
| Current ratio | 0.56 | 0.23 | 0.01 | 0 | 0.01 | |
| Interest coverage | 0 | 0 | -5.94 | -2.47 | -38.66 | |
| Income quality | 0.52 | 0.74 | 0.31 | 0.17 | 0.47 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 2.95 | 1.02 | 5.84 | 20.75 | 33.93 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.2 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0.05 | 0.04 | 0.04 | 0.04 | |
| ROIC | -1.01 | 6.02 | 3.42 | 1.31 | -0.97 | |
| Return on tangible assets | -0.09 | -1.01 | -71.76 | 0 | -1.02 | |
| Graham Net | 0 | -0.02 | -0.01 | -0.01 | -0.02 | |
| Working capital | -138.77K | -540.59K | -191.88K | -274.09K | -329.09K | |
| Tangible asset value | -45.73K | -386.51K | -187.49K | -274.09K | -329.45K | |
| Net current asset value | -138.77K | -613.01K | -191.88K | -274.09K | -671.05K | |
| Invested capital | 0 | -0.49 | -0.36 | -0.49 | -1.45 | |
| Average receivables | 1.45K | 44.89K | 43.44K | 0 | 0 | |
| Average payables | 23.55K | 78.04K | 54.49K | 441.5 | 5.83K | |
| Average inventory | 41.51K | 67.2K | 29.9K | 867 | 0 | |
| Days sales outstanding | 140.38 | 130.65 | 0 | 0 | 0 | |
| Days payables outstanding | 6.77K | 121.44 | 0 | 185.87 | 428.87 | |
| Days of inventory on hand | 10.98K | 64.7 | 6.17 | 0 | 0 | |
| Receivables turnover | 2.6 | 2.79 | 0 | 0 | 0 | |
| Payables turnover | 0.05 | 3.01 | 0 | 1.96 | 0.85 | |
| Inventory turnover | 0.03 | 5.64 | 59.2 | 0 | 0 | |
| ROE | -1.14 | 1.01 | 2.51 | 0.8 | 1.07 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-08-31 for Q1
| Metric | History | 2022-08-31 | 2022-11-30 | 2023-02-28 | 2023-05-31 | 2023-08-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Tangible book value per share | 0 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Share holders equity per share | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
| Interest debt per share | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Market cap | 8.54M | 2.76M | 3.2M | 3.5M | 1.28M | |
| Enterprise value | 8.67M | 2.99M | 3.8M | 4.18M | 1.92M | |
| P/E ratio | -23.09 | -22.43 | -4.87 | -13.01 | -4.95 | |
| Price to sales ratio | 0 | 0 | 1.28K | 466.41 | 171.12 | |
| POCF ratio | -147.43 | -71.84 | -63.63 | -201.22 | -392.47 | |
| PFCF ratio | -147.43 | -71.84 | -63.63 | -201.22 | -392.47 | |
| P/B Ratio | -37.54 | -12.19 | -11.75 | -10.62 | -3.34 | |
| PTB ratio | -37.54 | -12.19 | -11.75 | -10.62 | -3.34 | |
| EV to sales | 0 | 0 | 1.52K | 557.6 | 255.57 | |
| Enterprise value over EBITDA | -93.84 | -109.69 | -25.05 | -67.44 | -32.18 | |
| EV to operating cash flow | -149.76 | -77.91 | -75.62 | -240.57 | -586.18 | |
| EV to free cash flow | -149.76 | -77.91 | -75.62 | -240.57 | -586.18 | |
| Earnings yield | -0.01 | -0.01 | -0.05 | -0.02 | -0.05 | |
| Free cash flow yield | -0.01 | -0.01 | -0.02 | 0 | 0 | |
| Debt to equity | -0.59 | -1.2 | -2.24 | -1.45 | -1.65 | |
| Debt to assets | 4.21 | 3.91 | 1.68 | 1.38 | 1.99 | |
| Net debt to EBITDA | -1.46 | -8.54 | -3.97 | -11.03 | -10.64 | |
| Current ratio | 0 | 0.24 | 0.02 | 0.01 | 0.01 | |
| Interest coverage | 0 | -43.52 | -38.53 | -15.24 | -14.64 | |
| Income quality | 0.63 | 1.21 | 0.31 | 0.26 | 0.05 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 62.08 | 8.35 | 8.02 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 1.33 | |
| Graham number | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | |
| ROIC | 1 | -0.67 | -0.24 | -0.19 | -0.1 | |
| Return on tangible assets | -2.88 | -0.44 | -0.45 | -0.19 | -0.2 | |
| Graham Net | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | |
| Working capital | -227.42K | -122.11K | -259.97K | -329.09K | -385.99K | |
| Tangible asset value | -195.38K | -226.13K | -272.23K | -329.45K | -384.2K | |
| Net current asset value | -227.42K | -257.11K | -629.58K | -671.05K | -699.47K | |
| Invested capital | -0.59 | -1.2 | -2.24 | -1.45 | -1.65 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 16.9K | 28.24K | 14.18K | 7.78K | 16.59K | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 188.29 | 141.01 | 293.28 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0.48 | 0.64 | 0.31 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.41 | 0.14 | 0.6 | 0.2 | 0.17 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
CSUI Frequently Asked Questions
What is Cannabis Suisse Corp. stock symbol ?
Cannabis Suisse Corp. is a US stock , located in Bell gardens of Ca and trading under the symbol CSUI
What is Cannabis Suisse Corp. stock quote today ?
Cannabis Suisse Corp. stock price is $0.022 today.
Is Cannabis Suisse Corp. stock public?
Yes, Cannabis Suisse Corp. is a publicly traded company.
Company Profile
- Volume Average 24.86K
- Market Capitalization 1.02M
- CEO Mr. Scott Mcalister
- Headquarters Bell Gardens,CA,US
- IPO Date 2019-05-10
-
Website
https://www.cannabissuissecorp.com 
Cannabis Suisse Corp. engages in the cultivation, production, and distribution of over-the-counter products, recreational tobacco products, and medical CBD oils. The company sells its products through Swiss4Life, a retail brand for online selling, as well as a network of retailers. It provides health-related supplements, and face masks and disinfectants, as well as retails cigarettes. The company was formerly known as Geant Corp. and changed its name to Cannabis Suisse Corp. in February 2019. Cannabis Suisse Corp. was incorporated in 2016 and is based in Bell Gardens, California.
